Asthma Meds Linked to Tx Failure in Older Patients – Monthly Prescribing Reference (registration)


Monthly Prescribing Reference (registration)

Asthma Meds Linked to Tx Failure in Older Patients
Monthly Prescribing Reference (registration)
A study in the American Journal of Respiratory and Critical Care Medicine reports that older asthma patients, particularly those treated with inhaled corticosteroids, appear to be at an increased risk for treatment failure compared to those under the
Public Release: 12-Jun-2015 Older asthma patients at increased risk for EurekAlert (press release)
Older asthma patients at increased risk for treatment failureMedical Xpress
Asthma Treatments Fail Older Patients More Often: StudyHealthDay

all 9 news articles »

View full post on asthma – Google News

Public Release: 12-Jun-2015 Older asthma patients at increased risk for … – EurekAlert (press release)


Monthly Prescribing Reference (registration)

Public Release: 12-Jun-2015 Older asthma patients at increased risk for
EurekAlert (press release)
Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids, according to a new study. "Asthma morbidity and mortality are known to be increased in middle-aged and older
Older asthma patients at increased risk for treatment failureMedical Xpress
Asthma Meds Linked to Tx Failure in Older PatientsMonthly Prescribing Reference (registration)
Asthma Treatments Fail Older Patients More Often: StudyHealthDay

all 9 news articles »

View full post on asthma – Google News

Prediagnostic lung function impairment common in older asthma patients – News-Medical.net


News-Medical.net

Prediagnostic lung function impairment common in older asthma patients
News-Medical.net
Older adults with newly diagnosed asthma are not only more likely to have pre-existing lung function impairment than younger adults, but they also experience a more rapid decline of lung function, a Danish team reports in Respiratory Medicine. “Our

View full post on asthma – Google News

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   Asthma
Interventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  Advair
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

UofL Researchers to Examine Asthma Triggers in Older Adults – Newswise (press release)


Newswise (press release)

UofL Researchers to Examine Asthma Triggers in Older Adults
Newswise (press release)
Newswise — LOUISVILLE, Ky. – Although often considered a childhood health problem, asthma – a chronic inflammatory disease that causes recurrent cough, wheezing and chest tightness or shortness of breath – can cause serious illness for people age 60 …

View full post on asthma – Google News